Stockreport

Guillain-Barre Syndrome Pipeline Review, H2 2018 - Therapeutics Analysis of 6 Companies & Drug Profiles - ResearchAndMarkets.com

Akari Therapeutics Plc - American Depositary Shares  (AKTX) 
US:NASDAQ Investor Relations: investor.akaritx.com/investor-relations
PDF DUBLIN--(BUSINESS WIRE)-- The "Guillain-Barre Syndrome - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. [Read more]